Interactions of Indomethacin with Functionalized Rhombellanes – a Molecular Docking Study by Raluca Pop & Dušanka Janežič




  O R I G I N A L  S C I E N T I F I C  P A P E R    
 
 
 Croat. Chem. Acta 2019, 92(4), 503–509 
 Published online: March 28, 2020 




Interactions of Indomethacin with Functionalized 
Rhombellanes – a Molecular Docking Study 
 
Raluca Pop,1,* Dušanka Janežič2 
 
 
1 Faculty of Pharmacy, University of Medicine and Pharmacy “Victor Babeş” Timisoara, Eftimie Murgu Square 2, 300041 Timişoara, Romania 
2 Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Koper, Slovenia 
* Corresponding author’s e-mail address: pop.raluca@umft.ro 
 
RECEIVED: October 17, 2019    REVISED: January 20, 2020    ACCEPTED: January 20, 2020 
 
  THIS PAPER IS DEDICATED TO THE MEMORY OF PROFESSOR MIRCEA V. DIUDEA, AN EXCELLENT RESEARCHER AND COLLEAGUE AND DEDICATED MENTOR   
 
Abstract: The specific properties of carbon-based nanomaterials like fullerenes and graphenes have attracted a continuous interest for their 
possible use as drug carriers. The functionalization of these nanomaterials can lead to the variation or improvement of the required properties, 
in order to lead to the design of the most suitable compounds within a specific field. In this regard, the possible use of a new class of 
nanostructures -the rhombellanes- as nanocarriers is investigated. The aim of the paper is to study the interactions of indomethacin and four 
analogues with anti-inflammatory activity on 13 rhombellanes (three of them with a hyper-adamantane motif, Ada-rbl, three cube-rhombellane 
homeomorphs, C-rbl, and seven cube-rhombellane-ether/amine structures). Five compounds with anti-inflammatory activity have been docked 
to the surface of the rhombellanes; comparisons with the results obtained for fullerene C60 have been performed. The best binding affinities 
for the indomethacin and its derivatives have been obtained for two types of rhombellanes, Ada-rbl and C-rbl. The indomethacin analogue I4 
shows an increased binding affinity for C-rbl.420, similar to the value obtained for C60. Best results have been obtained for rhombellane 
derivatives characterized by smaller HOMO-LUMO gaps. 
 





NFLAMMATION is a defensive response of the body that 
causes physiological adaptations in order to minimize 
tissue damage and eliminate pathogenic infections. Such 
mechanisms involve a complex series of cellular phenom-
ena, including dilatation of arterioles and capillaries with in-
creased vascular permeability, as well as migration of 
leukocytes into the inflamed area. Chronic inflammation is an 
important factor contributing to morbidity and mortality, 
and may lead to diseases such as arthritis, osteoarthritis, 
retinitis, multiple sclerosis, psoriasis, and atherosclerosis.[1–3] 
 In this regard, some of the most commonly used clas-
ses of compounds are non-steroidal anti-inflammatory 
drugs; an important representative of this class of com-
pounds being the indomethacin. The basic structure of the 
indomethacin consists of an indole and a benzene ring, 
linked by a carbonyl group. 
 Non-steroidal anti-inflammatory drugs (NSAIDs) are 
widely used to treat minor pain and manage edema and tis-
sue damage that may occur in arthritis. In addition to anti-
inflammatory activity, a large number of compounds in this 
class also have antipyretic activity and are used in the treat-
ment of fever. In most cases, the therapeutic action of 
these compounds is manifested by the inhibition of prosta-
glandin biosynthesis.[4–6]  
 As a result, NSAIDs are characterized by the presence 
of a carboxyl group, being relatively strong organic acids; 
their lipophilic character may vary due to the presence of 
the different substituents attached to the phenyl ring.[7] In 
silico evaluation of the anti-inflammatory effects of indole 
derivatives like isoindoline,[8] indomethacin-based an-
alogs[9] and indole-N-acyl hydrazones[10] outlined their 
potential as selective COX-2 inhibitors. 
 Within the last years, nanomaterials have become 
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Ligand R1 R2 R3 
I (Indomethacin) OH CO Cl 
I1 OH CH2 - 
I2 NH2 CH2 - 
I3 OH CH2 Cl 
I4 OH CH2 SCH3 
 
Figure 1. General structure of the investigated compounds. 
 
Technology) and electronic industries to chemistry and 
environmental applications. Due to their unique character-
istics like small sizes, various surfaces and adjustable prop-
erties, they gained an important role in every industry. The 
medicine field is not an exception to this increased interest 
for applications of nanomaterials; there are various studies 
that outline the possibility of using them as drug carriers, 
for medical imaging and disease diagnoses.[11–13] 
 The present paper aims to investigate the interac-
tions between some anti-inflammatory bioactive com-
pounds (indomethacin and four derivatives) and a new 
class of nanostructures, the rhombellanes. The rhombel-
lane structures were proposed and defined by Diudea;[14,15] 
all their strong rings are rhombs/squares and they  
can be considered functionalized derivatives of 
bicyclo[1.1.1]pentane. Detailed information regarding their 
construction is given elsewhere,[14] and the structural spec-
ifications of the 13 rhombellanes that are investigated 
within the present study are presented in Table 1. (The 
structures of the 13 rhombellanes are included in the 
supplementary file of the paper).  
 As mentioned before, the investigated ligands are 
the indomethacin and four derivatives where the N-benzoyl 
moiety has been replaced by N-benzyl.[16] According to 
literature data,[16] N-benzyl analogues have been found to 
exhibit an enhanced biologic activity (compared to the N-
benzoyl ones). This way, the main structural change of the 
indomethacin derivatives consists in the replacement of 
the linking C=O group with a CH2 one, together with the 
presence/absence of the substituents on the phenyl cycle. 
The general structure of the investigated ligands[16] is given 
in Figure 1. 
 
MATERIALS AND METHOD 
This paper continues the exploring of bioactive molecules 
by molecular docking and QSAR methods developed by one 
of us (D. J) together with Topo Group Cluj. The method uses 
the binding affinities collected by a molecular docking pro-
cedure and submit them to an algorithm using a hyper-
molecule that mimics the receptor and takes account of  
the orientation of ligands with respect to the hyper-
molecule;[17–20] fragment mass and/or partial charges are 
used to quantify the ligand superposition over the hyper-
molecule and perform the QSAR models. The above-
mentioned docking methodology[18–20] and AutoDock Vina 
software[21] have been successfully employed for analyzing 
the interactions of 40 caffeine derivatives with poly(A)RNA 
polymerase protein Cid1.[19] Another study[18] dealt with 
the development of a new knowledge-based method that 
identifies the possible biosiosteric replacements. AutoDock 
Vina[21] was employed for the evaluation of the newly 
obtained compound, which obtained a similar score when 
compared to the original compound. Also, the most promi-
nent non-covalent interactions among some new synthe-
sized Schiff bases, A-DNA and B-DNA have been identified 
throughout a docking study performed with AutoDock 
Vina[20]. The structures of the indomethacin and its ana-
logues have been optimized, the vibrational analysis prov-
ing that true minima have been obtained. For the 
rhombellane structures, a single point computation has 
been performed. The energies of the HOMO and LUMO 
orbitals, the polarizability,[22,23] magnetizability[24] and the 
dipole moment have been computed by means of ADF soft-
ware,[25–27] at BLYP/TZP level of theory.[28] The descriptors 
of the molecular shape[29] (ovality, solvent accessible sur-
face, Connolly solvent excluded volume) and the partition 
coefficient logP have been obtained with Chem3D soft-
ware. Multiwfn 3.3.7[30] has been used for the graphical 
representation of the HOMO orbitals, while Autodock 
Vina[21] has been employed for the docking simulation. The 








BK e  (1) 
 
where ΔGB is the binding affinity (J mol–1), R – gas constant 
(J mol–1 K–1), T – temperature (298 K). 
 
RESULTS AND DISCUSSION 
Ligand Characterization 
Prior to the docking studies, a number of parameters 
including the molecular shape descriptors, magnetic 
properties, hydrophobic/hydrophilic character and frontier 
molecular energies have been computed.  
 The frontier molecular orbitals HOMO and LUMO 
play an important role in determining the reactivity of the 
various regions of the molecules. In this regard, detailed 
information regarding their energy and distribution can 
also be useful in docking studies, where the interactions 
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 The results depicted in Table 1 outline a small 
decrease of the HOMO energy and of the overall HOMO-
LUMO gap together with the replacement of the carbonyl 
group (R2) between the indole and benzene rings with 
methylene; the lowest stability has been predicted for the 
indomethacin derivative I2, characterized by the presence 
of CONH2 group and the lack of the chlorine on the phenyl 
cycle.  
 Concerning the localization of the frontier molecular 
orbitals of indomethacin, the HOMO orbital (for indometh-
acin) is located on the indole skeleton and, to a lesser 
extent, on the linking group (CO) between the indole ring 
and the benzene ring. (Figure 2; graphical representation of 
the HOMO orbitals for ligands I1–I4 is included within the 
Supplementary Material). 
 The absence of the C=O group, which provides an 
extended conjugation for indomethacin and which has 
been replaced by a methylene group in derivatives I1–I4, 
leads to a change in the distribution of molecular orbitals. 
Thus, in the case of the four analogs of indomethacin, the 
LUMOs mainly appear on the C-atoms of the indole cycle 
and on the functional groups COR (COOH and CONH2, re-
spectively). The replacement of the COOH group with 
CONH2 or the absence of Cl in position 4 of the benzene 
skeleton does not affect the distribution of orbitals.  
 Other parameters that can influence the binding 
affinity of molecules are the ones related to the shape, 
hydrophilic or hydrophobic character, and the number of 
hydrogen bond acceptors or donors. An accurate descrip-
tion of the molecular shape leads to valuable information 
regarding the prediction of reactivity and molecular inter-
actions. Ovality is the parameter that characterizes the 
deviation from the spherical shape to an oval one; in other 
words, ovality represents the difference between the larg-
est and smallest outer diameter on a cross-section of the 
compound.[24] The solvent accessible surface is the surface 
area of a bioactive compound that is accessible to a solvent. 
It is frequently used for the computation of the free energy 
required to transfer a compound between polar/non-polar 
environments. On the other hand, Connolly solvent 
excluded volume is the volume contained within the 
contact molecular surface.[24] 
 According to the obtained results, all the 
investigated ligands are characterized by an identical 
number of hydrogen bond acceptors and donors, and 
similar values for parameters like ovality and polarizability. 
The presence of a bulky group in I4 (SCH3) leads to slightly 
increased values of the shape parameters (compared to 
compounds I–I3). The replacement of the carbonyl group of 
indomethacin (I) with a methylene one (I3) influences only 
the dipole moment value. The molecular shape descriptors, 
the polarizability and the hydrophobic character outlined 
by the logP values are almost identical for ligands I and I3. 
As regards the I1 ligand, the replacement of the C=O group 
and the removal of the Cl atom lead to a diminished solvent 
 
Figure 2. Localization of the HOMO orbitals for indo-
methacin. 
 
Table 1. Frontier molecular orbitals energies and computed 
HL gap (BLYP/TZP) of the investigated indomethacin 
derivatives. 
Ligands EHOMO / eV ELUMO / eV HL gap / eV 
I –8.512 1.263 9.775 
I1 –7.947 1.304 9.251 
I2 –7.731 1.408 9.139 
I3 –8.056 1.199 9.255 
I4 –7.945 1.241 9.186 
 
Table 2. Global parameters of the ligands: solvent accessible area, solvent excluded volume, ovality, partition coefficient, dipole 
moment and the number of hydrogen bond acceptors and donors. 
Ligands Solvent accessible area / Å2 
Connolly Solvent 
Excluded Volume / Å3 





I 583.24 278.04 1.497 4.180 2.519 3 1 
I1 555.71 266.55 1.463 3.894 2.503 3 1 
I2 563.91 270.96 1.472 2.934 4.914 3 1 
I3 580.82 281.09 1.485 4.607 6.329 3 1 
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accessible area and magnetizability. For the ligand I3, 
removal of the chlorine from the benzene ring and 
replacement of COOH group with CONH2 leads to a 
lowering of the hydrophobic character. The replacement of 
the chlorine atom with thiomethyl does not influence the 
overall hydrophobicity of I4 ligand. According to the results 
depicted in Table 3, the absence of a substituent on the 
phenyl cycle results in the lower values of the solvent 
accessible surface and magnetizability. 
Docking Studies 
A number of 13 compounds within the class of rhombel-
lanes have been considered for evaluating their interac-
tions with indomethacin and its analogues, in order to 
evaluate their possible use as drug delivery systems. For 
comparison, fullerene C60 has been employed as reference 
compound. Their structure specification is presented in 
table below (all the structures are depicted in the Supple-
mentary Material). 
 As in the case of the investigated ligands, a short 
evaluation of their global properties has been performed. 
The results depicted in Table 5 include the computed 
HOMO-LUMO gap and dipole moment; HL gaps less than or 
equal to 2 eV have been obtained for C-rbl.348, C-rbl.360, 
Ada-rbl.240, Ada-rbl.300, Core (ether.B).132 and C60.  
 The results of the best binding affinities (Table 6; 
best binding affinities- bold, second best binding affinities- 
Table 3. Polarizabilities and magnetizabilities of compounds 
I-I4 computed at the BLYP/TZP level of theory. 
Ligands Polarizability / a.u. Magnetizability / a.u. 
I 269.73 –714.75 
I1 246.64 –368.05 
I2 248.59 –390.53 
I3 259.19 –660.73 
I4 285.36 –705.30 
 
Table 4. Polarizabilities and magnetizabilities of compounds 
I-I4 computed at the BLYP/TZP level of theory. 







Core (ether).108 4:(6(3).B(3).0.0) 
Core (ether).120 4:(6(6).B(3).0.0) 
Core (ether.B).132 4:(6(3).6(3).0.0) 
Core (amine).156 4:(6(6).6(3).0.0) 
Core (amine).168 4:(6(6).6(6).0.0) 
Core (ether).132 4:(6(6).B(3).0.0) 




Table 5. Polarizabilities and magnetizabilities of compounds I-I4 computed at the BLYP/TZP level of theory. 
Compounds EHOMO / eV ELUMO / eV HOMO-LUMO gap / eV Dipole moment / D 
Ada–rbl.240 –6.038 –4.099 1.939 2.612 
Ada–rbl.276 –7.670 –4.866 2.804 0 
Ada–rbl.300 –5.230 –3.226 2.004 7.201 
C–rbl.348 –6.038 –4.613 1.425 0.040 
C–rbl.360 –6.555 –5.151 1.404 2.875 
C–rbl.420 –6.310 –3.530 2.780 0 
Core (ether).108 –6.174 –2.013 4.161 0.020 
Core (ether).120 –5.386 –1.931 2.518 1.674 
Core (ether.B).132 –3.781 –1.332 1.518 0.935 
Core (amine).156 –4.515 –1.224 3.291 3.831 
Core (amine).168 –4.515 –1.414 3.101 2.890 
Core (ether).132 –5.630 –1.958 3.672 0.014 
Core (ether).144 –5.483 –1.719 3.764 5.398 
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italic) outline that very close or equal values to the one cor-
responding to fullerene C60 have been obtained both for 
all the C-rbl derivatives and Ada-rbl.240. The above- 
mentioned structures are characterized by smaller HOMO-
LUMO gaps (only C-rbl.420 has a HL gap higher than 2 eV, 
namely 2.78 eV). The influence of the HOMO-LUMO gap is 
outlined by the docking results of the structures with 108-
144 atoms; the highest binding affinity among them is 
attributed to Core (ether.B).132, which also has the lowest 
HL gap (1.518 eV) within the group. 
 
Table 6. The final Lamarckian genetic algorithm docked state - best binding affinities of ligands with the nanostructures  
(kcal mol–1).(a) 
The best binding affinity / kcal mol–1 
Compounds I I1 I2 I3 I4 
Ada-rbl.240 –4.6 –4.7 –5.2 –5.1 –4.8 
Ada-rbl.276 –4.7 –4.5 –4.7 –4.6 –4.5 
Ada-rbl.300 –4.7 –4.6 –4.7 –4.8 –4.5 
C-rbl.348 –5.0 –4.7 –5.0 –5.1 –5.0 
C-rbl.360 –5.1 –4.8 –5.0 –5.0 –4.9 
C-rbl.420 –5.0 –4.8 –5.1 –5.0 –5.2 
Core (ether).108 –3.5 –3.4 –3.5 –3.5 –3.3 
Core (ether).120 –3.7 –3.6 –3.8 –3.8 –3.8 
Core (ether.B).132 –4.3 –4.1 –4.4 –4.4 –4.2 
Core (amine).156 –3.4 –3.3 –3.4 –3.4 –3.4 
Core (amine).168 –3.4 –3.3 –3.3 –3.4 –3.3 
Core (ether).132 –3.1 –3.1 –3.2 –3.1 –3.1 
Core (ether).144 –3.4 –3.3 –3.6 –3.5 –3.4 
C60 –5.7 –5.0 –5.4 –5.5 –5.2 
(a) Lamarckian genetic algorithm (LGA) is a hybrid algorithm, a combination of the genetic and local search algorithms 
 
Table 7. Binding affinity ratio relative to ligand-fullerene C60 and calculated constant binding balance KB. 
 Binding affinity rhombellanes/Binding affinity C60 KB (constant binding balance) 
 I I1 I2 I3 I4 I I1 I2 I3 I4 
Ada-rbl.240 0.81 0.94 0.96 0.93 0.92 2364.3 2799.3 6512.6 5500.7 3314.3 
Ada-rbl.276 0.82 0.90 0.87 0.84 0.86 2799.3 1996.9 2799.3 2364.3 1996.9 
Ada-rbl.300 0.82 0.92 0.87 0.87 0.86 2799.3 2364.3 2799.3 3314.3 1996.9 
C-rbl.348 0.88 0.94 0.93 0.93 0.96 4645.9 2799.3 4645.9 5500.7 4645.9 
C-rbl.360 0.89 0.96 0.93 0.91 0.94 5500.7 3314.3 4645.9 4645.9 3924.0 
C-rbl.420 0.88 0.96 0.94 0.91 1 4645.9 3314.3 5500.7 4645.9 6512.6 
Core (ether).108 0.61 0.68 0.65 0.64 0.63 368.9 311.6 368.9 368.9 263.2 
Core (ether).120 0.65 0.72 0.70 0.69 0.73 517.2 436.8 612.3 612.3 612.3 
Core (ether.B).132 0.75 0.82 0.81 0.80 0.81 1424.6 1016.2 1686.6 1686.6 1203.2 
Core (amine).156 0.60 0.66 0.63 0.62 0.65 311.6 263.2 311.6 311.6 311.6 
Core (amine).168 0.60 0.66 0.61 0.62 0.63 311.6 263.2 263.2 311.6 263.2 
Core (ether).132 0.54 0.62 0.59 0.56 0.60 187.7 187.7 222.3 187.7 187.7 
Core (ether).144 0.60 0.66 0.66 0.64 0.63 311.6 263.2 436.8 368.9 311.6 
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 Due to the fact that the calculated values of the 
HOMO-LUMO gaps are influenced by the chosen method 
and basis set,[31,32] another computation at the PBE/TZP level 
of theory has been performed. The results are depicted in the 
Supplementary File (see Table S6) and it can be seen that the 
small differences have no influence on the HL gap hierarchy 
within the present group of nanostructures. 
 Among the investigated rhombellanes, indometha-
cin and its analogues show the highest affinity towards the 
rhombellanes with an increased number of atoms (240, 
348, 360 and 420). The analysis of the docking results out-
lines that the main interactions are the stacking interac-
tions between the aromatic moieties of the ligands and 
rhombellanes. Two hydrogen bonds are formed, one be-
tween the NH2 group of I2 analogue and the carbonyl group 
of nanostructure Ada_rbl.240, while the second hydrogen 
bond is established between the amino group of the nano-
material and the carbonyl group of the ligand I3. 
 Table 7 depicts the ratio of binding affinities (rhom-
bellanes):binding affinity (C60) and the constant binding val-
ues; the larger values suggest an increased binding affinity 
and sustain the results presented in Table 6. 
 
CONCLUSIONS 
A docking study of five ligands (indomethacin and four de-
rivatives) on 13 new structures within the class of rhombel-
lanes has been performed, aiming to determine the possible 
use of the rhombellanes as drug carriers. According to the 
computed binding affinities for ligand-rhombellane 
complexes, there are four structures that gave similar results 
to the ones obtained for the reference ligand-fullerene C60 
complex. For the first ligand, indomethacin, the highest ratio 
rhombellane/C60 is 0.89 and is attributed to C-rbl.360. As 
regards the second ligand (derivative I1), an improved ratio 
of 0.96 has been obtained both for C-rbl.360 and C-rbl.420. 
Ada-rbl.240 gave the best binding affinity for ligands I2 and 
I3 (0.96 and 0.93, respectively), while the complex C-rbl.420–
I4 has an equal binding affinity to the C60-I4 complex.  
 The results suggest that the rhombellane structures 
that are characterized by a smaller HOMO-LUMO gap are 
the most favored for higher binding affinity values to the 
indomethacin derivatives.  
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